<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Fri, 22 Aug 2025 10:27:37 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Semtech Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</title><link>https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47281428/semtech-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revis</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/22/Semtech-Sign-At-Hq-In-Silicon-Valley--Se.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Latest Ratings for SMTC Date Firm Action From To Nov 2021 B. Riley Securities Maintains Buy Nov 2021 Oppenheimer Maintains Outperform Sep 2021 Oppenhe...</description><pubDate>Fri, 22 Aug 2025 14:51:13 GMT</pubDate></item><item><title>Parents Feel The Pinch As Back-To-School Shopping Gets 9% Costlier Amid Trump's Trade War</title><link>https://www.benzinga.com/news/education/25/08/47280761/parents-feel-the-pinch-as-back-to-school-shopping-gets-9-costlier-amid-trumps-trade-war</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/22/Education-School-Student-Computer-Networ.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>The ongoing trade war has led to a 9% year-over-year increase in online apparel and accessory prices in July, making back-to-school shopping more expe...</description><pubDate>Fri, 22 Aug 2025 14:35:38 GMT</pubDate></item><item><title>A-Living's Turnaround Initiatives Paying Off</title><link>https://www.benzinga.com/markets/asia/25/08/47280626/a-livings-turnaround-initiatives-paying-off</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/22/A-Living900x600.png?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Fri, 22 Aug 2025 14:18:35 GMT</pubDate></item><item><title>Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting</title><link>https://www.benzinga.com/news/fda/25/08/47280567/biohaven-advances-toward-potential-first-fda-approved-therapy-for-spinocerebellar-ataxia-fda-drops-advis</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/22/FDA.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expected in late 2025. read mo...</description><pubDate>Fri, 22 Aug 2025 14:14:12 GMT</pubDate></item><item><title>Leading And Lagging Sectors For August 22, 2025</title><link>https://www.benzinga.com/insights/sector-etfs/25/08/47280333/leading-and-lagging-sectors-for-august-22-2025</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>read more</description><pubDate>Fri, 22 Aug 2025 14:10:09 GMT</pubDate></item></channel></rss>